U.S. Markets close in 1 hr 2 mins

The Zacks Analyst Blog Highlights: Companhia de Saneamento Basico do Estado de Sao Paulo, Cemig, iShares MSCI Brazil ETF and Inovio Pharmaceuticals

Zacks Equity Research

For Immediate Release

Chicago, IL – August 08, 2016 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Companhia de Saneamento Basico do Estado de Sao Paulo (SBS), Cemig (CIG), iShares MSCI Brazil ETF ( EWZ) and Inovio Pharmaceuticals (INO).

Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1Stock of the Day pick for free.

Here are highlights from Friday’s Analyst Blog:

Play Rio 2016 Olympics with These Stocks and ETFs

Tonight marks the opening ceremonies of the 2016 Summer Olympics in Brazil. While the summer games have come a long way from naked Greco Roman wrestling, doesn’t sound like the Brazilian infrastructure has made the leap. I’m not going to sit here and destroy the Brazilians, the Germans already did that in the World Cup. I’m here to figure out a way to make money on these games.

We know that the sewage is absolutely out of control in Brazil. Those poor sailors, rowers and canoers have to hold their breath. These beaches look like an episode of “Hoarders” and the water is so nasty Newsweek called it the “Poop Olympics.”

Guanabara Bay makes the Chicago River look like the river flowing out of the Garden of Eden. The Associated Press took sample of water last year and the levels of viruses from human waste were at 1.7 million times what would be considered unsafe at California beaches.

Here’s an idea, why not a buy a Brazilian water sanitation company? If anything, this global humiliation should get the government to start writing some checks to get this cleaned up. Check out Companhia de Saneamento Basico do Estado de Sao Paulo (SBS). That’s Portuguese for the basic sanitation company of the state of Sao Paulo, right around the corner from Rio. Ticker SBS is a Zacks Rank #2 (Buy) with Value and Growth Style Scores of A. The company is coming off two quarterly beats in a row, with the last one coming in at 24 cents versus our Zacks Consensus Estimate of 20 cents.

The Guanabara Bay isn’t the only place you’ll find rolling brownouts in Brazil. Consider looking at other infrastructure plays like Cemig (CIG). Cemig is actually a Zacks Ran k#2 (Buy) right now as well. Of course if you don’t want to buy specific infrastructure plays here, you can play the hope of Olympic momentum through the iShares MSCI Brazil ETF (EWZ). This will get you exposure to stocks traded on Brazil’s largest exchange, the BOVESPA.

Don’t forget about Zika. The virus that’s wreaking havoc on South and Central America doesn’t yet have a vaccine. But Inovio Pharmaceuticals (INO) has been working on a DNA-based vaccine since December. Inovio is going to report earnings before the market opens Monday August 8th.

Every time you share this video, the good old U.S. of A. wins another Gold medal. Chime in the comments section below and tell me how much you love Eric’s editing. Subscribe to the YouTube channel, Twitter @bartosiastics and come back here for all the Trending Stocks with Zacks.com, I’m Dave Bartosiak.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1Stock of the Day pick for free.

About Zacks Equity Research

Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.

Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.

Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today.

About Zacks

Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978. The later formation of the Zacks Rank, a proprietary stock picking system; continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros.

Follow us on Twitter: https://twitter.com/zacksresearch

Join us on Facebook: https://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339



Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
SABESP -ADR (SBS): Free Stock Analysis Report
CEMIG SA -ADR (CIG): Free Stock Analysis Report
ISHARS-BRAZIL (EWZ): ETF Research Reports
INOVIO PHARMAC (INO): Free Stock Analysis Report
To read this article on Zacks.com click here.